Powder Diffraction Journal

Articles highlighting Active Pharmaceutical Ingredients (APIs)

Kaduk, J.A., Crowder, C.E., Zhong, K., Fawcett, T.G. and Suchomel, M.R. (2014) ‘Crystal structure of atomoxetine hydrochloride (Strattera), C17H22NOCl’, Powder Diffraction, 29(3), pp. 269–273. doi: 10.1017/S0885715614000517.

Kaduk, J.A., Crowder, C.E., Zhong, K., Fawcett, T.G. and Suchomel, M.R. (2014) ‘Crystal structure of dutasteride (Avodart), C27H20F6N2O2’, Powder Diffraction, 29(3), pp. 274–279. doi: 10.1017/S088571561400061X.

Kaduk, J.A., Reid, J.W., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2015) ‘Crystal structure of solifenacin hydrogen succinate, C23H27N2O2(HC4H4O4)’, Powder Diffraction, 30(3), pp. 211–217. doi: 10.1017/S0885715615000329.

Kaduk, J.A., Zhong, K., Blanton, T.N., Gindhart, A.M. and Fawcett, T.G. (2015) ‘Powder X-ray diffraction of darunavir ethanolate, C27H37N3O7S(C2H5OH)’, Powder Diffraction, 30(3), pp. 298–299. doi: 10.1017/S0885715615000536.

Kaduk, J.A., Zhong, K., Blanton, T.N., Gindhart, A.M. and Fawcett, T.G. (2015) ‘Powder X-ray diffraction of saxagliptin hydrochloride dihydrate, C18H26N3O2Cl(H2O)2’, Powder Diffraction, 30(3), pp. 296–297. doi: 10.1017/S0885715615000548.

Kaduk, J.A., Crowder, C.E. and Zhong, K. (2014) ‘Crystal structure of folic acid dihydrate, C29H29N2O6(H2O)2’, Powder Diffraction, 30(1), pp. 52–56. doi: 10.1017/S0885715614000815.

Kaduk, J.A., Zhong, K. and Blanton, T.N. (2015) ‘Crystal structure of rilpivirine, C22H18N6’, Powder Diffraction, 30(2), pp. 170–174. doi: 10.1017/S0885715615000196.

Kaduk, J.A., Zhong, K., Blanton, T.N., Gates, S. and Fawcett, T.G. (2015) ‘Powder X-ray diffraction of levothyroxine sodium pentahydrate, C15H10I4NNaO4(H2O)5’, Powder Diffraction, 30(4), pp. 370–371. doi: 10.1017/S0885715615000676.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2015) ‘Crystal structure of salmeterol xinafoate form I (Serevent®Diskus®), (C25H37NO4)(C11H8O3)’, Powder Diffraction, 30(4), pp. 333–339. doi: 10.1017/S0885715615000743.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2015) ‘Crystal structure of ziprasidone hydrochloride monohydrate, C21H22Cl2N4OS(H2O)’, Powder Diffraction, 30(3), pp. 192–198. doi: 10.1017/S0885715615000305.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2016) ‘Crystal structure of choline fenofibrate (Trilipix®), (C5H14NO) (C17H14ClO4)’, Powder Diffraction, 31(2), pp. 142–148. doi: 10.1017/S0885715616000099.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2016) ‘Crystal structure of paliperidone, C23H27FN4O3’, Powder Diffraction, 31(2), pp. 135–141. doi: 10.1017/S0885715616000087.

Kaduk, J.A., Crowder, C.E., Zhong, K., Fawcett, T.G. and Suchomel, M.R. (2014) ‘Powder X-ray diffraction of albuterol sulfate (C13H22NO3)2SO4’, Powder Diffraction, 29(2), p. 202. doi: 10.1017/S0885715614000232.

Kaduk, J.A., Crowder, C.E., Zhong, K., Fawcett, T.G. and Suchomel, M.R. (2014) ‘Powder X-ray diffraction of ibandronate sodium monohydrate, C9H22NNaO7P2(H2O)’, Powder Diffraction, 29(2), p. 201. doi: 10.1017/S0885715614000244.

Kaduk, J.A., Crowder, C.E., Zhong, K., Fawcett, T.G. and Suchomel, M.R. (2014) ‘Powder X-ray diffraction of risedronate sodium hemipentahydrate, C7H10NNaO7P2(H2O)2.5’, Powder Diffraction, 29(2), p. 200. doi: 10.1017/S0885715614000256.

Kaduk, J.A., Crowder, C.E., Zhong, K., Fawcett, T.G. and Suchomel, M.R. (2014) ‘Powder X-ray diffraction of vancomycin hydrochloride, C66H76Cl3N9O24’, Powder Diffraction, 29(2), p. 199. doi: 10.1017/S0885715614000268.

Kaduk, J.A., Zhong, K., Blanton, T.N. and Gates, S. (2015) ‘Crystal structure of levalbuterol hydrochloride polymorph A (Xopenex), C13H22NO3Cl’, Powder Diffraction, 30(2), pp. 158–162. doi: 10.1017/S0885715615000172.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2015) ‘Crystal structure of fingolimod hydrochloride, C19H34ClNO2’, Powder Diffraction, 30(3), pp. 205–210. doi: 10.1017/S0885715615000317.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2015) ‘Crystal structure of lacosamide form I, C13H18N2O3’, Powder Diffraction, 30(3), pp. 224–230. doi: 10.1017/S0885715615000378.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2015) ‘Crystal structure of nilotinib, C28H22F3N7O’, Powder Diffraction, 30(3), pp. 270–277. doi: 10.1017/S0885715615000512.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2015) ‘Crystal structure of raltegravir potassium, C20H20FKN6O5’, Powder Diffraction, 30(3), pp. 263–269. doi: 10.1017/S0885715615000470.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2015) ‘Crystal structure of sitagliptin dihydrogen phosphate monohydrate, C16H16F6N5O(H2PO4)(H2O)’, Powder Diffraction, 30(4), pp. 349–356. doi: 10.1017/S0885715615000755.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2015) ‘Crystal structure of tramadol hydrochloride, C16H26NO2Cl’, Powder Diffraction, 30(3), pp. 242–249. doi: 10.1017/S088571561500041X.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2016) ‘Crystal structure of citalopram hydrobromide, C20H22FN2OBr’, Powder Diffraction, 31(3), pp. 176–184. doi: 10.1017/S0885715616000178.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2016) ‘Crystal structure of mupirocin form I, C26H44O9’, Powder Diffraction, 31(2), pp. 118–125. doi: 10.1017/S088571561600004X.

Kaduk, J.A., Zhong, K., Gindhart, A.M. and Blanton, T.N. (2016) ‘Crystal structure of rivastigmine hydrogen tartrate Form I (Exelon®), C14H23N2O2(C4H5O6)’, Powder Diffraction, 31(2), pp. 97–103. doi: 10.1017/S0885715616000038.

Reid, J.W., Kaduk, J.A., Garimella, S.V. and Tse, J.S. (2014) ‘Rietveld refinement using synchrotron powder diffraction data for curcumin, C21H20O6, and comparison with density functional theory’, Powder Diffraction, 30(1), pp. 67–75. doi: 10.1017/S0885715614001018.

See current issue here

Cambridge